These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 26708508)

  • 1. Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma.
    Crommentuijn MH; Maguire CA; Niers JM; Vandertop WP; Badr CE; Würdinger T; Tannous BA
    Mol Oncol; 2016 Apr; 10(4):625-34. PubMed ID: 26708508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene delivery of apoptin-derived peptide using an adeno-associated virus vector inhibits glioma and prolongs animal survival.
    Zhong X; Zhao H; Liang S; Zhou D; Zhang W; Yuan L
    Biochem Biophys Res Commun; 2017 Jan; 482(3):506-513. PubMed ID: 28212737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracranial AAV-IFN-β gene therapy eliminates invasive xenograft glioblastoma and improves survival in orthotopic syngeneic murine model.
    GuhaSarkar D; Neiswender J; Su Q; Gao G; Sena-Esteves M
    Mol Oncol; 2017 Feb; 11(2):180-193. PubMed ID: 28098415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor-related apoptosis-inducing ligand and induces an alternative cell death pathway.
    Badr CE; Wurdinger T; Nilsson J; Niers JM; Whalen M; Degterev A; Tannous BA
    Neuro Oncol; 2011 Nov; 13(11):1213-24. PubMed ID: 21757445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic anticancer neural stem cells in combination with a cardiac glycoside for glioblastoma therapy.
    Teng J; Hejazi S; Badr CE; Tannous BA
    Stem Cells; 2014 Aug; 32(8):2021-32. PubMed ID: 24801379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic AAV9-IFNβ gene delivery treats highly invasive glioblastoma.
    GuhaSarkar D; Su Q; Gao G; Sena-Esteves M
    Neuro Oncol; 2016 Nov; 18(11):1508-1518. PubMed ID: 27194146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral decorin gene delivery by AAV vector inhibits brain glioblastomas and prolongs survival of animals by inducing cell differentiation.
    Ma HI; Hueng DY; Shui HA; Han JM; Wang CH; Lai YH; Cheng SY; Xiao X; Chen MT; Yang YP
    Int J Mol Sci; 2014 Mar; 15(3):4393-414. PubMed ID: 24625664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model.
    Yoo J; Choi S; Hwang KS; Cho WK; Jung CR; Kwon ST; Im DS
    J Gene Med; 2006 Feb; 8(2):163-74. PubMed ID: 16144019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling brain tumor growth by intraventricular administration of an AAV vector encoding IFN-beta.
    Meijer DH; Maguire CA; LeRoy SG; Sena-Esteves M
    Cancer Gene Ther; 2009 Aug; 16(8):664-71. PubMed ID: 19197327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle engineered TRAIL-overexpressing adipose-derived stem cells target and eradicate glioblastoma via intracranial delivery.
    Jiang X; Fitch S; Wang C; Wilson C; Li J; Grant GA; Yang F
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13857-13862. PubMed ID: 27849590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted induction of apoptosis in glioblastoma multiforme cells by an MRP3-specific TRAIL fusion protein in vitro.
    Wang LH; Ni CW; Lin YZ; Yin L; Jiang CB; Lv CT; Le Y; Lang Y; Zhao CY; Yang K; Jiao BH; Yin J
    Tumour Biol; 2014 Feb; 35(2):1157-68. PubMed ID: 24272336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitor panobinostat potentiates the anti-cancer effects of mesenchymal stem cell-based sTRAIL gene therapy against malignant glioma.
    Choi SA; Lee C; Kwak PA; Park CK; Wang KC; Phi JH; Lee JY; Chong S; Kim SK
    Cancer Lett; 2019 Feb; 442():161-169. PubMed ID: 30367915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Peripherally Derived Neural-Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas.
    Birbrair A; Sattiraju A; Zhu D; Zulato G; Batista I; Nguyen VT; Messi ML; Solingapuram Sai KK; Marini FC; Delbono O; Mintz A
    Stem Cells Transl Med; 2017 Feb; 6(2):471-481. PubMed ID: 28191774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma.
    Li M; Sun S; Dangelmajer S; Zhang Q; Wang J; Hu F; Dong F; Kahlert UD; Zhu M; Lei T
    Stem Cell Res Ther; 2019 Mar; 10(1):88. PubMed ID: 30867058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors.
    Redjal N; Zhu Y; Shah K
    Stem Cells; 2015 Jan; 33(1):101-10. PubMed ID: 25186100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice.
    Shi J; Zheng D; Liu Y; Sham MH; Tam P; Farzaneh F; Xu R
    Cancer Res; 2005 Mar; 65(5):1687-92. PubMed ID: 15753363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
    Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
    Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice.
    Ma H; Liu Y; Liu S; Xu R; Zheng D
    Hepatology; 2005 Dec; 42(6):1355-63. PubMed ID: 16317690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of adenovirally expressed soluble TRAIL in human glioma organotypic slice culture and glioma xenografts.
    Liu Y; Lang F; Xie X; Prabhu S; Xu J; Sampath D; Aldape K; Fuller G; Puduvalli VK
    Cell Death Dis; 2011 Feb; 2(2):e121. PubMed ID: 21368892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
    Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
    Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.